The Centers for Medicare & Medicaid Services unveiled a new program for alternative payment model participants that would allow clinicians to use products containing CBD as part of patient care plans. In response, the Food and Drug Administration vowed not to further restrict the sale of oral hemp products.
The majority of recent journal studies evaluating the performance of AI algorithms failed to adequately validate test results, according to a meta-analysis published in the Korean Journal of Radiology, meaning most of that research can only serve as proof-of-concept and might not translate into clinical performance.
New York City Mayor Bill de Blasio declared a public health emergency April 9 following a measles outbreak within the city, requiring individuals in affected zip codes to get vaccinated or face a $1,000 fine.
The future direction of AI research and development will fall into the hands of just nine global companies—three from China and six from the U.S.—Forbes reported April 10.
AI is poised to make a sizable impact on healthcare this year, but we’ll likely see the greatest dent in the areas of medical imaging, diagnostics and suicide risk prediction, according to data presented at the Partners HealthCare World Medical Innovation Forum in Boston.
As incidents producing mass casualties can occur anywhere at any time, leadership at trauma centers of all levels do well to prepare. A good place to start is learning from the experiences of urban hospitals dealing with shooting victims every day or close to it.
